Answers are grounded in this paper and cite their sources.
We report our experience of biologic treatment in patients with immune-mediated inflammatory diseases and a recent personal history of cancer. Two registries were interrogated: (i) the MISTIC registry, which includes patients with a chronic inflammatory dermatological, rheumatic and/or gastroenterological disease who had started biologics since 2007, and (ii) the local tumour registry of the Doubs district. In total, 94 patients were included in 2 cohorts: 28 patients with cancer diagnosed within 5 years before starting biologics (cohort 1) and 66 patients who developed cancer during biologic treatment (cohort 2).
No takes yet. Share an insight, caveat, or question.
Hennemann et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: